These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23434498)

  • 1. Comparative potencies of contemporary generic vancomycin lot: in vitro assay results from nine products and a reference reagent-grade sample.
    Jones RN; Watters AA; Flamm RK; Sader HS
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):237-8. PubMed ID: 23434498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More potency assay results for generic non-USA lots of piperacillin/tazobactam and initial reports for generic meropenem compounds marketed in the USA.
    Jones RN; Sader HS; Flamm RK; Watters AA
    Diagn Microbiol Infect Dis; 2013 May; 76(1):110-2. PubMed ID: 23490010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots.
    Moet GJ; Watters AA; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):319-22. PubMed ID: 19822271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn, Wyeth) formulation.
    Jones RN; Fritsche TR; Moet GJ
    Diagn Microbiol Infect Dis; 2008 May; 61(1):76-9. PubMed ID: 18221852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
    Sader HS; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
    Sader HS; Becker HK; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):329-31. PubMed ID: 20159377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin.
    Fujimura S; Watanabe A; Fuse K; Kikuchi T; Gomi K; Tokue Y
    Int J Antimicrob Agents; 2008 Apr; 31(4):391-2. PubMed ID: 18308516
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of a reference lot of Mueller-Hinton agar.
    Pollock HM; Barry AL; Gavan TL; Fuchs PC; Hansen S; Thornsberry CL; Frankel H; Forsythe SB
    J Clin Microbiol; 1986 Jul; 24(1):1-6. PubMed ID: 3088028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
    Sader HS; Fritsche TR; Jones RN
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heterogeneity of Brain Heart Infusion agar media (BHI): effects on the determination of the vancomycin and the teicoplanin minimal inhibitory concentrations (MIC) of Staphylococcus aureus strains].
    Martin C
    Pathol Biol (Paris); 2004 Oct; 52(8):450-4. PubMed ID: 15465263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):329-32. PubMed ID: 16263233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
    Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    Sader HS; Jones RN; Rossi KL; Rybak MJ
    J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demonstration of an inoculum effect on the estimation of the minimal inhibitory concentration of LY 146032].
    Flandrois JP; Carret G; Pichat C; Peyret M
    Pathol Biol (Paris); 1988 May; 36(5):377-80. PubMed ID: 2841637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in Canada.
    Boyd DA; Du T; Hizon R; Kaplen B; Murphy T; Tyler S; Brown S; Jamieson F; Weiss K; Mulvey MR
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2217-21. PubMed ID: 16723588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test.
    Block C; Robenshtok E; Simhon A; Shapiro M
    J Hosp Infect; 2000 Oct; 46(2):147-52. PubMed ID: 11049709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.